Evidence map›Paper›PMID 23540695›Full record

ArticleCell2013

Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

Lin Cheng, Zhi Huang, Wenchao Zhou, Qiulian Wu, Shannon Donnola, James K Liu, Xiaoguang Fang, Andrew E Sloan, Yubin Mao, Justin D Lathia and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 538 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
538citing papers in PubMed, 1 pooled it
35.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

538 citing papers in PubMed, 1 synthesis or guideline pooled it, 880 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Biomimetic Scaffold-Based 3D Models for Decoding Cancer Biology and Advancing Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Understanding Glioblastoma Dynamics Using 3D Organoids and Engineered Extracellular Matrix.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

478 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Lin ChengDepartment of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Zhi Huang
Wenchao Zhou
Qiulian Wu
Shannon Donnola
James K Liu
Xiaoguang Fang
Andrew E Sloan
Yubin Mao
Justin D Lathia
Wang Min
Roger E McLendon
Jeremy N Rich
Shideng Bao
Cleveland Clinic Lerner College of Medicine · USCleveland Clinic · USDuke Medical Center · USUniversity Hospitals of Cleveland · USXiamen University · CNYale University · US

Funding

The role of signaling molecule AIP1 in pathological angiogenesisR01HL115148 · NHLBI · YALE UNIVERSITY · PI KYRIAKIDES, THEMIS R · 2013 to 2021
$3.6M
Molecular Targeting of L1CAM to Inhibit Glioblastoma Stem Cell InvasionR01NS070315 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI BAO, SHIDENG · 2010 to 2014
$1.7M
NHLBI NIH HHS R01 HL115148NINDS NIH HHS R01 NS070315
6 · The paper itself

Abstract

Glioblastomas (GBMs) are highly vascular and lethal brain tumors that display cellular hierarchies containing self-renewing tumorigenic glioma stem cells (GSCs). Because GSCs often reside in perivascular niches and may undergo mesenchymal differentiation, we interrogated GSC potential to generate vascular pericytes. Here, we show that GSCs give rise to pericytes to support vessel function and tumor growth. In vivo cell lineage tracing with constitutive and lineage-specific fluorescent reporters demonstrated that GSCs generate the majority of vascular pericytes. Selective elimination of GSC-derived pericytes disrupts the neovasculature and potently inhibits tumor growth. Analysis of human GBM specimens showed that most pericytes are derived from neoplastic cells. GSCs are recruited toward endothelial cells via the SDF-1/CXCR4 axis and are induced to become pericytes predominantly by transforming growth factor β. Thus, GSCs contribute to vascular pericytes that may actively remodel perivascular niches. Therapeutic targeting of GSC-derived pericytes may effectively block tumor progression and improve antiangiogenic therapy.

Indexed as

AnimalsBrainBrain NeoplasmsCell DifferentiationEndothelial CellsGlioblastomaHumansMiceMice, Inbred BALB CMice, NudeNeoplasm TransplantationNeoplastic Stem CellsPericytesTransforming Growth Factor betaTransplantation, HeterologousTransforming Growth Factor beta

Identifiers

PMID23540695
PMCPMC3638263
OpenAlexW2026480865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.